🇺🇸 FDA
Pipeline program

STRO-004

STRO-004-ST1

Phase 1 small_molecule active

Quick answer

STRO-004 for Head and Neck Squamous Cell Carcinoma HNSCC is a Phase 1 program (small_molecule) at SUTRO BIOPHARMA, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
SUTRO BIOPHARMA, INC.
Indication
Head and Neck Squamous Cell Carcinoma HNSCC
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials